CD&R and McKesson to take Option Care Health private for $5.8B

Option Care Health agreed to be acquired by private equity firm CD&R and drug distributor McKesson for $32.05 per share in cash. The deal values the home and alternate-site infusion provider at about $5.8 billion. The offer is a roughly 37% premium to Option Care's October 5 closing price.

Why it matters: Pairing a buyout firm with a strategic heavyweight like McKesson is an unusual structure that signals strong appetite for infusion services outside the hospital.